EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Transitioning from Subtyping to Precision Medicine in Parkinson's Disease: A Purpose‐Driven Approach

Connie Marras, Seyed-Mohammad Fereshtehnejad iD, Daniela Berg, Nicolaas I Bohnen iD, Kathy Dujardin iD, Roberto Erro iD, Alberto J Espay, Glenda Halliday iD, Jacobus J Van Hilten, Michele T Hu, Beomseok Jeon iD, Christine Klein und 8 weitere

Movement Disorders · 2024-03 · 39 (3) · 462-471

DOI: 10.1002/mds.29708 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Movement Disorders, online erschienen am 20.01.2024. Verfasst von Connie Marras und 19 weiteren Autor:innen. Beteiligte Einrichtung: Edmond J. Safra Program in Parkinson's Disease and the Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, University Heal…. Hauptthemen laut MEDLINE: Parkinson Disease. Die Arbeit wurde bisher 52-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The International Parkinson and Movement Disorder Society (MDS) created a task force (TF) to provide a critical overview of the Parkinson's disease (PD) subtyping field and develop a guidance on future research in PD subtypes. Based on a literature review, we previously concluded that PD subtyping requires an ultimate alignment with principles of precision medicine, and consequently novel approaches were needed to describe heterogeneity at the individual patient level. In this manuscript, we present a novel purpose‐driven framework for subtype research as a guidance to clinicians and researchers when proposing to develop, evaluate, or use PD subtypes. Using a formal consensus methodology, we determined that the key purposes of PD subtyping are: (1) to predict disease progression, for both the development of therapies (use in clinical trials) and prognosis counseling, (2) to predict response to treatments, and (3) to identify therapeutic targets for disease modification. For each purpose, we describe the desired product and the research required for its development. Given the current state of knowledge and data resources, we see purpose‐driven subtyping as a pragmatic and necessary step on the way to precision medicine. © 2024 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseHumansPrecision MedicineDisease ProgressionAdvisory Committees

Stichwörter der Autor:innen

Parkinson's diseaseheterogeneitypurposesubtypes

Autor:innen und Institutionen

  • Edmond J. Safra Program in Parkinson's Disease and the Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada.
  • Division of Neurology, Department of Medicine, The Ottawa Hospital, University of Ottawa, Ottawa, Ontario, Canada.
  • Department of Neurology, Christian-Albrechts-University, Kiel, Germany.
  • Departments of Radiology & Neurology, University of Michigan, University of Michigan Udall Center, Ann Arbor, Michigan, USA.
  • Center of Excellence for Parkinson's Disease, CHU Lille, Univ Lille, Inserm, Lille Neuroscience & Cognition, Lille, France.
  • Department of Medicine, Surgery and Dentistry "Scuola Medica Salernitana", Neuroscience Section, University of Salerno, Baronissi, Italy.

ORCID-Profile: Seyed-Mohammad Fereshtehnejad, Nicolaas I Bohnen, Kathy Dujardin, Roberto Erro, Glenda Halliday, Beomseok Jeon, Albert F G Leentjens, Brit Mollenhauer, Ronald B Postuma, Mayela Rodríguez-Violante, Tiago A Mestre

Zitieren

APA

Marras, C., Fereshtehnejad, S. M., Berg, D., Bohnen, N. I., Dujardin, K., Erro, R., Espay, A. J., Halliday, G., Van Hilten, J. J., Hu, M. T., Jeon, B., Klein, C., Leentjens, A. F. G., Mollenhauer, B., Postuma, R. B., Rodríguez-Violante, M., Simuni, T., Weintraub, D., Lawton, M., & Mestre, T. A. (2024). Transitioning from Subtyping to Precision Medicine in Parkinson's Disease: A Purpose‐Driven Approach. Movement Disorders, 39(3), 462-471. https://doi.org/10.1002/mds.29708

Vancouver

Marras C, Fereshtehnejad SM, Berg D, Bohnen NI, Dujardin K, Erro R, et al. Transitioning from Subtyping to Precision Medicine in Parkinson's Disease: A Purpose‐Driven Approach. Movement Disorders. 2024;39(3):462-471. doi:10.1002/mds.29708

BibTeX
@article{Marras2024,
  author = {Marras, Connie and Fereshtehnejad, Seyed-Mohammad and Berg, Daniela and Bohnen, Nicolaas I and Dujardin, Kathy and Erro, Roberto and Espay, Alberto J and Halliday, Glenda and Van Hilten, Jacobus J and Hu, Michele T and Jeon, Beomseok and Klein, Christine and Leentjens, Albert F G and Mollenhauer, Brit and Postuma, Ronald B and Rodríguez-Violante, Mayela and Simuni, Tanya and Weintraub, Daniel and Lawton, Michael and Mestre, Tiago A},
  title = {Transitioning from Subtyping to Precision Medicine in Parkinson's Disease: A Purpose‐Driven Approach},
  journal = {Movement Disorders},
  year = {2024},
  volume = {39},
  number = {3},
  pages = {462--471},
  doi = {10.1002/mds.29708}
}
Kostenlos starten →